Health

TB Mukt Goa: State Launches Aggressive, Grassroots Health Campaign


Panaji, July 3, 2025 – In a decisive move to eliminate tuberculosis (TB), the Government of Goa has launched a statewide, multi-pronged public health campaign with the goal of becoming India’s first TB-free state by 2025. The campaign, part of the National Tuberculosis Elimination Program (NTEP), combines grassroots community engagement, financial aid, and digital health monitoring to tackle TB head-on.

Leadership and Vision

Goa’s Health Minister Vishwajit Rane highlighted the government’s commitment to a “unified and patient-centered approach” in the fight against TB. He reaffirmed that the state is investing in both infrastructure and human resources to ensure no TB patient is left behind.

“We are on track to achieve TB Mukt Goa,” said Rane. “Through coordinated efforts and accountability at every level, our vision is not just a reduction in TB, but total eradication.”


Nikshay Poshan Yojana: Supporting Patients, Nutritionally and Financially

A key pillar of the campaign is the Nikshay Poshan Yojana, a direct benefit transfer (DBT) scheme that provides nutritional support to TB patients. The government is actively collecting bank account details to ensure timely and transparent fund disbursement.

This move not only addresses malnutrition-related vulnerabilities but also builds trust and continuity in treatment adherence.


Strengthening Health Infrastructure and Monitoring

To improve TB care, the government has deployed:

  • Medical Officers
  • Community Health Officers (CHOs)
  • AYUSH doctors

These professionals are placed across all Primary Health Institutions and tasked with continuous care, follow-ups, and home-based support.

Under the Differentiated TB Care Model, CHOs:

  • Conduct bi-weekly home visits
  • Dispense treatment incentives
  • Record patient progress through the Nikshay portal

Each TB patient’s treatment progress is now geo-tagged, providing real-time tracking and improving accountability across the system.


Contact Tracing and Early Detection

Goa has also tightened its contact tracing protocols:

  • Every household contact of a TB patient is screened
  • High-risk individuals receive chest X-rays
  • Results are rapidly uploaded to the Nikshay system for early intervention

These measures significantly reduce diagnosis delays and enable faster medical response.


TB-Free Panchayats: Grassroots Movement in Action

The campaign also aims to create TB-Free Panchayats, with each panchayat required to meet six health criteria to qualify. Weekly updates are submitted to the Directorate of Health Services, ensuring continuous progress tracking.

Community partnerships are central to this initiative. Healthcare workers, local authorities, and residents collaborate to raise awareness, boost case detection, and foster a collective sense of responsibility.


A Long Road, but Strong Resolve

Despite registering around 2,000 new TB cases annually and facing a mortality rate higher than the national average, Goa’s comprehensive strategy reflects a determined and hopeful trajectory.

By integrating technology, community care, and financial support, the state is not just managing TB — it is moving toward eliminating it.

The Goal: TB Mukt Goa by 2025

With firm leadership, innovation, and grassroots mobilization, Goa is rewriting the narrative on tuberculosis in India. The state’s journey toward a TB-free future stands as a model for other regions to emulate.

Social

Molbio Diagnostics’ ProRad X-Ray Device Accelerates Early TB Detection in 100-Day Challenge



A total of more than 72 lakh devices of Truenat were installed in public setups and around 8 thousand in private setups nationally

The Government of India initiated the ambitious 100-Day TB Challenge aiming to accelerate nationwide efforts to screen, detect, and treat tuberculosis, reinforcing the country’s goal of eradicating the disease by 2025. This proactive health campaign sought to significantly improve early diagnosis and timely treatment interventions, particularly in remote and underserved regions. Molbio Diagnostics played a pivotal role in supporting this government initiative by deploying its cutting-edge diagnostic solutions, including the ultraportable ProRad Altas X-ray devices and the innovative Truenat molecular diagnostic platforms, which substantially enhanced the efficiency and reach of TB screening efforts across India

Molbio Diagnostics commemorated World Tuberculosis Day by highlighting the successful completion of India’s ambitious 100-Day TB Challenge, showcasing the extensive deployment and impactful performance of its cutting-edge diagnostic solutions. Central to this campaign were the ultraportable ProRad X-ray devices and the innovative Truenat molecular diagnostic platforms, offering an end-to-end TB screening and diagnosis solution that significantly enhanced screening, early diagnosis, and rapid detection of tuberculosis across the country. The strategic deployment of these advanced diagnostic tools reached extensive coverage across India’s diverse regions, with 8 ProRad devices in the North region, 21 ProRad units in the South region, 20 ProRad units in the East region, and 49 ProRad units in the West region.
The ProRad Atlas, an ultraportable x-ray device acclaimed for its portability and accuracy, facilitated rapid chest X-ray screenings, enabling early-stage identification of presumptive TB cases even in remote and underserved areas. Complementing these efforts, Molbio’s revolutionary Truenat platform—a portable, battery-operated real-time PCR platform—provided rapid, point-of-care TB detection, confirming cases with high accuracy in under an hour. Together, these technologies significantly accelerated India’s capacity for proactive screening, diagnosis, and treatment nationwide within the 100-day period.
Speaking on the success of the initiative, Mr. Sriram Natarajan, CEO of Molbio Diagnostics, remarked, “Molbio Diagnostics is committed to positively impacting public health through innovative and accessible diagnostic solutions. Our ProRad Atlas, and Truenat platforms represent our dedication to enhancing the healthcare ecosystem by enabling timely and accurate TB diagnosis, especially in underserved areas. We remain dedicated to supporting India’s vision of eliminating tuberculosis by 2025 and will continue driving advancements that strengthen public health outcomes nationwide.”
About Molbio Diagnostics
Molbio Diagnostics is a global point-of-care diagnostics company. With a commitment to providing rapid, reliable, and robust diagnostic solutions, Molbio brings advanced healthcare technologies to remote areas. The company’s flagship Truenat®️ real-time PCR platform is endorsed by the World Health Organization (WHO), enhancing infectious disease management worldwide. Molbio is dedicated to improving healthcare accessibility and quality with innovative diagnostics that meet global standards. Please visit us on https://www.molbiodiagnostics.com/